New Nanotechnology Drug to Control Blindness

June 26, 2015

(Medical Xpress) – The Mexican company “Medical and Surgical Center for Retina” has created a way to deliver drugs in order to avoid risks and painful treatments in people with secondary blindness due to chronic degenerative blindness such as diabetic retinopathy and degeneration of the eye. The innovative formula eliminates the need to administrate drugs by intraocular injection. It is a nanotechnology product, which works with last-generation liposome particles concentrated in droplets, which function as a conveyor that wraps proteins or antibody fragments and allows its passage into the eye. Once inside, it releases the drugs.